Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma per Jian Yang, Gaomeng Luo, Chang Li, Zhunlin Zhao, Sheng Ju, Qifan Li, Zhike Chen, Cheng Ding, Xin Tong, Jun Zhao

Obtenir text complet

Identification of TEFM as a potential therapeutic target for LUAD treatment per Wenxuan Hu, Jian Yang, Kang Hu, Gaomeng Luo, Zhike Chen, Zihao Lu, Yongsen Li, Xin Lv, Jun zhao, Chun Xu

Obtenir text complet

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma per Yuan Cui, Yuan Cui, Zhike Chen, Zhike Chen, Bin Pan, Bin Pan, Tong Chen, Hao Ding, Hao Ding, Qifan Li, Qifan Li, Li Wan, Gaomeng Luo, Gaomeng Luo, Lang Sun, Cheng Ding, Cheng Ding, Jian Yang, Jian Yang, Xin Tong, Xin Tong, Jun Zhao, Jun Zhao

Obtenir text complet

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma per Weibiao Zeng, Weibiao Zeng, Jin Wang, Jian Yang, Jian Yang, Zhike Chen, Zhike Chen, Yuan Cui, Yuan Cui, Qifan Li, Qifan Li, Gaomeng Luo, Gaomeng Luo, Hao Ding, Hao Ding, Sheng Ju, Sheng Ju, Baisong Li, Jun Chen, Jun Chen, Yufeng Xie, Yufeng Xie, Xin Tong, Xin Tong, Mi Liu, Jun Zhao, Jun Zhao

Obtenir text complet